Array BioPharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.02.14	Oncothyreon, Array BioPharma Announce Initiation Of Phase 1b Trial Of ONT-380 (RTTNews)
09.12.13	Array BioPharma Updates Clinical Data On ARRY-614 For Myelodysplastic Syndromes (RTTNews)
04.10.13	Morning Research: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc., and Array BioPharma Inc. (PR Newswire)
04.09.13	Array Biopharma To Present at the Morgan Stanley Global Healthcare Conference and the Stifel Healthcare Conference (PR Newswire)
29.08.13	Pre-Market Review: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc., and Array BioPharma Inc. (PR Newswire)
12.08.13	Financial Results Release, Management Changes, and Newly Issued Permits - Research Report on Valeant, Teva, Endo, Array, and Sequenom (PR Newswire)
07.08.13	Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2013 (PR Newswire)
30.07.13	SNTA Enchants, PRGO Picks Up ELN, Tech Glitches Mar CHTP, STXS On High Note (RTTNews)
30.07.13	After-market Movers For July 29 (HLF, X, AGNC, ARRY, GIMO, NATI) (RTTNews)
29.07.13	Array BioPharma, Celgene Announce Strategic R&D Collaboration - Quick Facts (RTTNews)
29.07.13	Array BioPharma And Celgene Corporation Announce Strategic global R&D Collaboration To Advance Medical Innovation To Benefit Patients (PR Newswire)
29.07.13	Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2013 On August 7, 2013 (PR Newswire)
24.07.13	Morning Research: Johnson & Johnson, Mylan, Array BioPharma, and Brookdale Senior Living (PR Newswire)
23.07.13	Tuesday's Biotech Watch List - Alliqua, BioCryst Pharmaceuticals, Trovagene, Delcath Systems, Array BioPharma (PR Newswire)
23.07.13	Pre-market Movers For July 23 (FIRE, NFLX, RSH, DD, ARRY, CSE, FTNT, PENN, CYTK) (RTTNews)
23.07.13	Array BioPharma: ARRY-502 Meets Primary And Secondary Endpoints In Asthma Study (RTTNews)
23.07.13	ARRY-502 Meets Primary And Key Secondary Endpoints In Asthma Study (PR Newswire)
22.07.13	After-market Movers For July 22 (NFLX, TXN, SANM, ARRY) (RTTNews)
04.06.12	Promising Data for KRAS Mutant Advanced NSCLC Patients Presented at ASCO (Businesswire)
04.06.12	MEK162 Shows Promising Clinical Activity in Ongoing Phase 2 Trial (Businesswire)
30.05.12	Array BioPharma to Present at the Jefferies 2012 Global Healthcare Conference (Businesswire)
16.05.12	Array BioPharma Announces Clinical Data Presentations at the 2012 ASCO Annual Meeting (Businesswire)
15.05.12	Array BioPharma and Genentech's Strategic Alliance Voted Breakthrough Alliance of 2012 (Businesswire)
30.04.12	Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2012 (Businesswire)
30.04.12	Array BioPharma Names Liam Ratcliffe, M.D., Ph.D., to Board of Directors (Businesswire)
26.04.12	Array BioPharma Names Ron Squarer Chief Executive Officer (Businesswire)
16.04.12	Array BioPharma Names Howard Holden, Ph.D., Vice President of Regulatory Affairs and Quality Assurance (Businesswire)
04.04.12	Encouraging Selumetinib Results Announced for Phase 2 Trial in Ovarian Cancer (Businesswire)
27.02.12	Array BioPharma to Present at the Cowen and Company 32nd Annual Health Care Conference (Businesswire)
14.02.12	Array BioPharma Announces Closing of Public Offering of Common Stock and Exercise of Overallotment Option (Businesswire)
09.02.12	Array BioPharma to Present at the Leerink Swann Global Healthcare Conference (Businesswire)
09.02.12	Array BioPharma Announces Proposed Public Offering of Common Stock (Businesswire)
08.02.12	Array BioPharma Announces Proposed Public Offering of Common Stock (Businesswire)
30.01.12	Array BioPharma Names Gwen A. Fyfe, M.D. to Board of Directors (Businesswire)
30.01.12	Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2012 (Businesswire)
17.01.12	Array BioPharma's Chief Executive Officer Robert E. Conway Resigns (Businesswire)
04.01.12	Array BioPharma to Present at the 30th Annual J.P. Morgan Healthcare Conference (Businesswire)
12.12.11	ARRY-614 Demonstrates Positive Single Agent Activity in Patients with Myelodysplastic Syndromes (Businesswire)
12.12.11	ARRY-520 Demonstrates Durable Single-Agent Activity in Patients with Advanced Multiple Myeloma (Businesswire)
01.12.11	A New Era in Pharmaceutical Innovation Means Major Challenges for the Industry (Businesswire)
01.12.11	Array BioPharma to Host Analyst and Investor Day Featuring Distinguished Clinical Investigators (Businesswire)
29.11.11	Array Biopharma to Present Clinical Data on ARRY-520, a KSP Inhibitor, and ARRY-614, a Dual p38/Tie2 Inhibitor, at the 2011 American Society of Hematology Annual Meeting (Businesswire)
17.11.11	Aetna and the Center for Biomedical Informatics at Harvard Medical School Announce Research Collaboration (Businesswire)
17.11.11	Array BioPharma to Present at the Piper Jaffray Health Care Conference (Businesswire)
09.09.11	Array BioPharma Names Karsten Witt, M.D., Vice President of Clinical Sciences (Businesswire)
01.04.11	On Sale Now at Barnes & Noble’s NOOK Bookstore™: The Best of Vanity Fair: Elizabeth Taylor - Eight Remarkable Stories About Hollywood’s Most Beautiful, Most Controversial Star (Businesswire)
31.01.11	Bar Harbor Bankshares Reports Record 2010 Earnings (Businesswire)
09.08.10	Vitesse Announces Third Quarter Fiscal Year 2010 Results (Businesswire)
03.05.10	Herbalife Ltd. Announces Record First Quarter Revenue and Raises FY’10 EPS Guidance (Businesswire)
03.05.10	Max Capital Group Reports First Quarter 2010 Results (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

06.02.25		Handel in Frankfurt: TecDAX auf grünem Terrain
06.02.25		Gewinne in Frankfurt: MDAX mittags mit grünem Vorzeichen
06.02.25		TecDAX-Handel aktuell: TecDAX legt zum Start zu
05.02.25		TecDAX aktuell: TecDAX letztendlich mit Gewinnen
05.02.25		MDAX aktuell: MDAX beendet den Handel in der Gewinnzone
05.02.25		Freundlicher Handel in Frankfurt: MDAX-Börsianer greifen nachmittags zu
05.02.25		Starker Wochentag in Frankfurt: TecDAX klettert am Mittwochnachmittag
05.02.25		Optimismus in Frankfurt: Das macht der MDAX am Mittwochmittag

06.02.25

Handel in Frankfurt: TecDAX auf grünem Terrain

06.02.25

Gewinne in Frankfurt: MDAX mittags mit grünem Vorzeichen

06.02.25

TecDAX-Handel aktuell: TecDAX legt zum Start zu

05.02.25

TecDAX aktuell: TecDAX letztendlich mit Gewinnen

05.02.25

MDAX aktuell: MDAX beendet den Handel in der Gewinnzone

05.02.25

Freundlicher Handel in Frankfurt: MDAX-Börsianer greifen nachmittags zu